James Anthony Otter

Octopus VCT Plc operates as a venture capital trust. It is engaged in the business of qualifying investments into companies which have contractual revenues from financially sound counterparties or which have a strong asset base. The company was founded in 2010 and is headquartered in London, the United Kingdom.

Octopus Apollo VCT Plc is a venture capital trust, which invests primarily in unquoted investment instruments, including ordinary and preference shares, loan stocks, and convertible securities. The company was founded on June 7, 2006 and is headquartered in London, the United Kingdom.

Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom.

Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom.

Hallmarq Veterinary Imaging Ltd. designs and manufactures clinical, research and industrial MRI systems. The company was founded by Martin Nicholas Bolas, Taylor David Graham, and Richard Stoner in 2000 and is headquartered in Guildford, the United Kingdom.

Axon Ltd. provides clinical software solutions. The firm serves for health care professionals, clinical researchers and the pharmaceutical industry. The company was founded by Paul Harding and Colin Harding in March 2006 and is headquartered in Hampshire, the United Kingdom.

Renovos Biologics Ltd. engages in the research and experimental development on biotechnology. It offers stem cell products, research services and nanoclay technologies. The company was founded by James Anthony Otter, Agnieszka Janeczek, Richard Oreffo and Jonathan Dawson on March 22, 2017 and is headquartered in Chilworth, the United Kingdom.